| Alberto Iaia, MD | |
|
5936 Limestone Rd, Suite 301, Hockessin, DE 19707-8905 | |
| (302) 234-5800 | |
| (302) 234-2380 |
| Full Name | Alberto Iaia |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 32 Years |
| Location | 5936 Limestone Rd, Hockessin, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336108026 | NPI | - | NPPES |
| 300101019 | Other | RAILROAD MEDICARE # | |
| 0000941501 | Medicaid | DE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | C1-0005621 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Christiana Care Health Services Inc | 9739097569 | 1248 |
| Christiana Care Health Services Inc | 9739097569 | 1248 |
News Archive
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.
Abortion and contraception coverage make news in Texas, Virginia and Pennsylvania while both sides prepare for the 40th anniversary of the Roe v. Wade decision.
Scientists have identified a key molecule responsible for triggering the chemical processes in our brain linked to our formation of memories. The findings, published in the journal Frontiers in Neural Circuits, reveal a new target for therapeutic interventions to reverse the devastating effects of memory loss.
Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm's drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
› Verified 3 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770568107 PECOS PAC ID: 9739097569 Enrollment ID: O20031201000477 |
News Archive
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.
Abortion and contraception coverage make news in Texas, Virginia and Pennsylvania while both sides prepare for the 40th anniversary of the Roe v. Wade decision.
Scientists have identified a key molecule responsible for triggering the chemical processes in our brain linked to our formation of memories. The findings, published in the journal Frontiers in Neural Circuits, reveal a new target for therapeutic interventions to reverse the devastating effects of memory loss.
Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm's drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
› Verified 3 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942553615 PECOS PAC ID: 9739097569 Enrollment ID: O20130115000049 |
News Archive
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.
Abortion and contraception coverage make news in Texas, Virginia and Pennsylvania while both sides prepare for the 40th anniversary of the Roe v. Wade decision.
Scientists have identified a key molecule responsible for triggering the chemical processes in our brain linked to our formation of memories. The findings, published in the journal Frontiers in Neural Circuits, reveal a new target for therapeutic interventions to reverse the devastating effects of memory loss.
Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm's drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
› Verified 3 days ago
| Entity Name | Christiana Care Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1245674993 PECOS PAC ID: 9739097569 Enrollment ID: O20130903000474 |
News Archive
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.
Abortion and contraception coverage make news in Texas, Virginia and Pennsylvania while both sides prepare for the 40th anniversary of the Roe v. Wade decision.
Scientists have identified a key molecule responsible for triggering the chemical processes in our brain linked to our formation of memories. The findings, published in the journal Frontiers in Neural Circuits, reveal a new target for therapeutic interventions to reverse the devastating effects of memory loss.
Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm's drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alberto Iaia, MD 4755 Ogletown Stanton Rd, Department Of Radiology, Newark, DE 19718-2200 Ph: (302) 733-1806 | Alberto Iaia, MD 5936 Limestone Rd, Suite 301, Hockessin, DE 19707-8905 Ph: (302) 234-5800 |
News Archive
A team of international scientists has made a significant breakthrough in understanding the cause of bile duct cancer, a deadly type of liver cancer. By identifying several new genes frequently mutated in bile duct cancers, researchers are paving the way for better understanding of how bile duct cancers develop. Their discovery is published online in Nature Genetics.
Abortion and contraception coverage make news in Texas, Virginia and Pennsylvania while both sides prepare for the 40th anniversary of the Roe v. Wade decision.
Scientists have identified a key molecule responsible for triggering the chemical processes in our brain linked to our formation of memories. The findings, published in the journal Frontiers in Neural Circuits, reveal a new target for therapeutic interventions to reverse the devastating effects of memory loss.
Provepharm, a French company specialized in the development of pharmaceutical applications, and Dr Franz Kohler Chemie, a German leader in the manufacture and supply of organ preservation solutions and antidote pharmaceuticals, today announce that they have entered into a partnership to launch Provepharm's drug product Methylthioninium chloride Proveblue 5mg/ml solution for injection (the Product) in Germany, for the acute symptomatic treatment of medicinal and chemical products-induced methaemoglobinaemia.
› Verified 3 days ago
Dr. Shabbir Ali Naqvi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5936 Limestone Rd Ste 301, Hockessin, DE 19707 Phone: 302-234-2380 | |
Paul J. Mccready, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5936 Limestone Rd, Suite 301, Hockessin, DE 19707 Phone: 302-234-5800 Fax: 302-234-2380 | |
Carlos Flores, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5936 Limestone Rd, Suite 301, Hockessin, DE 19707 Phone: 302-234-5800 Fax: 302-234-2380 | |
Fred T. Wang, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 12 Harvest Ln, Hockessin, DE 19707 Phone: 952-595-1100 Fax: 612-294-4903 | |
S. Barry Diznoff, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 5936 Limestone Rd, Suite 301, Hockessin, DE 19707 Phone: 302-234-5800 Fax: 302-234-2380 | |
Boris Reznikov, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5936 Limestone Rd, Suite 301, Hockessin, DE 19707 Phone: 302-234-5800 Fax: 302-234-2380 |